VaxGen and Raven to merge

Two South San Francisco biotech firms, the struggling VaxGen and Raven biotechnologies, inc., have agreed to merge in an all-shares transaction.

Shareholders in VaxGen, which has suffered a series of well-publicised setbacks including the failure of an AIDS vaccine in 2003, delisting from Nasdaq in 2004 and the loss of a U.S. government anthrax vaccine contract in 2006, will retain a majority of shares in the new company, the company said in a statement released Monday. Vaxgen will also assume the privately-held Raven’s debt and equipment lease obligations of approximately $1.8 million, and move its headquarters to Raven’s offices.

Vaxgen is required as part of the merger to relist with a national stock exchange, a step that company officials said is underway.

The merged company’s board will include four Vaxgen board members and three Raven board members. Raven CEO George F. Schreiner will serve as CEO and director of the new company, with Vaxgen President and CEO James P. Panek to serve as president and chief operating officer.

The combined company will have one compound for major cancer indications in clinical development, four oncology product candidates in preclinical development, and a library of antibodies to novel cancer antigens, the companies said in a statement.

Just Posted

Market Street is only the beginning of drive to clear city streets of cars

Car-free streets won’t stop at Market. At least, that’s the intent of… Continue reading

SF approves plans for a car-free Market Street

San Francisco will soon kick cars off one of its busiest thoroughfares… Continue reading

Black officials call out NAACP head for partisan politics

Conflicts reach a head after Rev. Amos Brown calls supervisors ‘racist’ for resisting Mayor Breed

Fire burning after explosion at energy facility in Contra Costa County

I-80 closed in both directions between state Highway 4 and Carquinez Bridge

Dueling behavioral health plans headed for March 2020 ballot as city leaders spar over reform plans

Update 5:10 p.m.: Mayor London Breed filed paperwork Tuesday that would place… Continue reading

Most Read